February 27, 2018 / 12:09 PM / 7 months ago

BRIEF-Recro Pharma Inc Reports Year End 2017 Financial Results

Feb 27 (Reuters) - Recro Pharma Inc:

* RECRO PHARMA REPORTS YEAR END 2017 FINANCIAL RESULTS

* RECRO PHARMA INC - FOR 2018, COMPANY EXPECTS REVENUE GENERATED FROM ITS CDMO DIVISION TO BE APPROXIMATELY $70 MILLION

* RECRO PHARMA INC - IV MELOXICAM NDA SUBMITTED AND PDUFA ACTION DATE SET FOR MAY 26, 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below